Myriad Genetics Secures Japan Approval for MyChoice® as Companion Diagnostic in Prostate Cancer

- Myriad Genetics Inc.,  a leader in molecular diagnostic testing and precision medicine,announced that Japan’s Ministry of Health, Labour and...

April 16, 2026 | Thursday | News
Illumina and D3b Launch Landmark Pediatric Genomics Dataset to Accelerate Precision Medicine

Dataset will drive crucial insights to accelerate scientific discovery and ultimately improve pediatric patient care.  Illumina (NASDAQ: ILMN) and...

April 16, 2026 | Thursday | News
Cepheid And Oxford Nanopore Expand Collaboration To Advance Rapid Pathogen Genomic Workflows

Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Cepheid, a Danaher company and a leader i...

April 16, 2026 | Thursday | News
Sana Biotechnology and Mayo Clinic Partner to Advance SC451 Cell Therapy for Type 1 Diabetes

Sana and Mayo Clinic to collaborate across multiple areas with goal of accelerating development of and access to potentially curative therapies for patie...

April 15, 2026 | Wednesday | News
Renaissance Pharma Secures FDA Fast Track and IND Clearance for Daretabart in High-Risk Neuroblastoma

FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk neuroblastoma and enabling ...

April 15, 2026 | Wednesday | News
Novo Nordisk Partners with OpenAI to Lead AI-Driven Transformation Across Drug Discovery and Operations

Strategic partnership enables upskilling of Novo Nordisk’s workforce and places the company at the forefront of AI transformation in healthcare ...

April 15, 2026 | Wednesday | News
Thermo Fisher Scientific Expands PPD™ Clinical Research Capabilities Through Strategic Data Collaboration with HealthVerity

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD...

April 15, 2026 | Wednesday | News
EU Expands Dupixent Approval to Young Children with Chronic Spontaneous Urticaria

Approval in CSU for children 2 to 11 years of age is based on data from the LIBERTY-CUPID clinical trial program, including an extrapolation of efficacy ...

April 14, 2026 | Tuesday | News
Neurocrine Advances Nxera-Discovered NBI-1117570 into Phase 2 for Schizophrenia

NBI-1117570 is an investigational oral, dual muscarinic M1/M4 selective receptor agonist discovered by Nxera advancing through clinical development und...

April 14, 2026 | Tuesday | News
SynOx Therapeutics Reports Strong Phase 3 TANGENT Results With Emactuzumab In TGCT

TANGENT met its primary and secondary endpoints with a high level of statistical significance vs. placebo at 6 months, including ORR by RECIST V1.1 and...

April 14, 2026 | Tuesday | News
GenScript and Mimulus Partner to Industrialize DNA Data Storage for the AI Era

The multi-year collaboration aims to scale molecular data storage infrastructure and unlock breakthrough cost efficiencies by 2030. GenScript Biotech Co...

April 13, 2026 | Monday | News
Nxera Pharma Achieves Second Milestone in Lilly Diabetes Collaboration

Nxera Pharma Co., Ltd. announces that it has achieved a second development milestone under its multi-target collaboration and license agreement with Eli ...

April 10, 2026 | Friday | News
Novartis Scales Global Community Health Efforts to Tackle Gaps in Chronic Disease Care

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program ...

April 10, 2026 | Friday | News
Emergent BioSolutions Expands Access to NARCAN Nasal Spray with New Carrying Case, Multipacks, and Campus Outreach Initiative

  Emergent BioSolutions Inc. announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the pub...

April 09, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close